î
îŒ
î
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
DMIIR0.140USD
0.000
ååŒæé ïŒETïŒ15åé
ãã®æ ªäŸ¡
--æ䟡ç·é¡
--çŽè¿12ã¶æPER
î
詳现æ å ± Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 äŒæ¥å
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãDMIIR
äŒç€ŸåDrugs Made In America Acquisition II Corp
äžå Žæ¥Sep 25, 2025
æé«çµå¶è²¬ä»»è
ãCEOãStockwell (Lynn)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Right
決ç®ææ«- -
æ¬ç€Ÿæåšå°1 East Broward Boulevard
éœåžFT LAUDERDALE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·33301
é»è©±çªå·19548703099
ãŠã§ããµã€ã
äŒæ¥ã³ãŒãDMIIR
äžå Žæ¥Sep 25, 2025
æé«çµå¶è²¬ä»»è
ãCEOãStockwell (Lynn)
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
ä»ã®
100.00%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
ä»ã®
100.00%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
ä»ã®
100.00%
æ©é¢æè³å®¶ä¿ææ ª
îäŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
ããŒã¿ãªã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
ããŒã¿ãªã
é¢é£ETF
îéæå
æ¯ç
ããŒã¿ãªã
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
çš®é¡
æ¯ç
ããŒã¿ãªã
ãããã質å
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îDrugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ãã
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯äœã§ããïŒ
îDrugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯ã
ä»ã®
ä»ã®
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ïŒDMIIRïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î--æç¹ã§ãDrugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®æ ªåŒãä¿æããŠããæ©é¢ã¯--瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ--ã§ãå
šäœã®--%ãå ããŠããŸãã--ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯--å¢å ããŠããŸãã
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®æ倧ã®åçæºã¯äœã§ããïŒ
î--ã«ãããŠã--éšéãDrugs Made In America Acquisition II Rights Exp 16 Sep 2030ã«ãšã£ãŠæ倧ã®åçãçã¿åºããŠããããã®éé¡ã¯--ã§ãå
šåçã®--%ãå ããŠããŸãã
